다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Windtree Therapeutics Inc (WINT)
Windtree Therapeutics Inc (WINT) 뉴스

WINT

Windtree Therapeutics (WINT)

Windtree Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:WINT

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/16	22:00	GlobeNewswire Inc.	Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference	NASDAQ:WINT	Windtree Therapeutics Inc
2024/12/09	22:00	GlobeNewswire Inc.	Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia	NASDAQ:WINT	Windtree Therapeutics Inc
2024/12/05	21:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/12/04	22:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/12/04	22:00	GlobeNewswire Inc.	Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/28	06:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/28	06:05	GlobeNewswire Inc.	Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/14	22:53	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/14	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/14	22:00	GlobeNewswire Inc.	Windtree Announces Leadership Transition Plan With Industry Veterans	NASDAQ:WINT	Windtree Therapeutics Inc
2024/11/04	22:00	GlobeNewswire Inc.	Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/30	21:00	GlobeNewswire Inc.	Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/23	21:00	GlobeNewswire Inc.	Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/21	21:00	GlobeNewswire Inc.	Windtree To Present at the ThinkEquity Conference on October 30th	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/17	21:15	GlobeNewswire Inc.	Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/09	21:00	GlobeNewswire Inc.	Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design	NASDAQ:WINT	Windtree Therapeutics Inc
2024/10/09	20:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/30	21:15	GlobeNewswire Inc.	Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/27	05:05	GlobeNewswire Inc.	Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/25	21:15	GlobeNewswire Inc.	Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/25	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/25	06:21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/04	21:00	GlobeNewswire Inc.	Windtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic Shock	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/04	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/04	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	22:10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	22:09	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	20:26	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:WINT	Windtree Therapeutics Inc
2024/09/03	20:22	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:WINT	Windtree Therapeutics Inc
2024/08/24	05:15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:WINT	Windtree Therapeutics Inc

검색 관련기사 보기:NASDAQ:WINT

1 2 3 4 5 6 7 8 9 다음 >>

Health Care Select Sector

US Dollar vs Sterling

Financial Select Sector

US Dollar vs Yen

Bank of America

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관